Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients (original) (raw)
Nephrotoxicity after ifosfamide
Alan Craft
Archives of Disease in Childhood, 1990
View PDFchevron_right
Ifosfamide nephrotoxicity in paediatric cancer patients
A. O'Meara
European Journal of Pediatrics, 1994
View PDFchevron_right
Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose
Alan Craft
Pediatric Blood & Cancer, 2010
View PDFchevron_right
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer
Antoinette Schouten-van Meeteren, Sebastiaan Knijnenburg
Reviews, 1996
View PDFchevron_right
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Odile Oberlin
Journal of Clinical Oncology, 2009
View PDFchevron_right
A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors
Hilmar Stolte
Investigational new drugs, 2000
View PDFchevron_right
PREDICTION OF NEPHROTOXICITY INDUCED BY CISPLATIN CHEMOTHERAPY IN CANCER PATIENTS
mai abdallah
View PDFchevron_right
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy
Edward Kovnar
Cancer research, 1987
View PDFchevron_right
Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers
Joëlle Nortier
Clinical Kidney Journal, 2017
View PDFchevron_right
Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma
laurence dubourg
Pediatric Nephrology, 1998
View PDFchevron_right
Effect of free creatine therapy on cisplatin-induced renal damage
abdulkerim bedir
Renal Failure, 2014
View PDFchevron_right
Risk factors for cisplatin-induced long-term nephrotoxicity in pediatric cancer survivors
Faruk Pınarlı
Pediatrics International, 2015
View PDFchevron_right
Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors
Jean-marc Ferrero
Pharmacotherapy
View PDFchevron_right
Cisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment Strategies
su lee
Electrolytes & Blood Pressure, 2014
View PDFchevron_right
Effect of Cytotoxic Medications (MTX, Cisplatin, 5 FU and cyclophosphamide against creatinine clearance Patient Relationships And Creatinine clearance Urea with Cancer Patients
Syed Zeeshan Gillani
View PDFchevron_right
Induction of chronic renal failure in goats using cisplatin: A new animal model
Tapan Mandal
Toxicology International, 2013
View PDFchevron_right
Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation
Mustafa Turan
2002
View PDFchevron_right
Cisplatin Nephrotoxicity: A Review
Kenneth Nugent
The American Journal of the Medical Sciences, 2007
View PDFchevron_right
Renal insufficiency in cancer patients: Prevalence and implications on anticancer drugs management. Final results of the “IRMA” study
Vincent Launay-vacher
Bone, 2006
View PDFchevron_right
Cisplatin dose rate as a risk factor for nephrotoxicity in children
Martin English
Brit J Cancer, 1998
View PDFchevron_right
Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients
Hiroyoshi Koide
In Vivo
View PDFchevron_right
Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen
François Avry
BMC cancer, 2024
View PDFchevron_right
Cisplatin-Associated Nephrotoxicity and Pathological Events
Ruhul Abid
Contributions to Nephrology, 2005
View PDFchevron_right
Renal Injury during Long-Term Crizotinib Therapy
Esteban Gabazza
International Journal of Molecular Sciences, 2018
View PDFchevron_right
Nephrotoxic injury and renal tissue repair associated with the administration of the anticancer drugs cisplatin and carboplatin
Denis Nonclercq
Micron and Microscopica Acta, 1989
View PDFchevron_right
Nephrotoxicity of High-Dose Ifosfamide/Carboplatin/Etoposide in Adults Undergoing Autologous Stem Cell Transplantation
Paul Zorsky
The American Journal of the Medical Sciences, 1997
View PDFchevron_right
Incidence of Acute Kidney Injury among Adult Cancer Patients Receiving Nephrotoxic Chemotherapy at King Abdulaziz University Hospital
Shadi Alkhayyat
2020
View PDFchevron_right
Nephrotoxicity Evaluation in Outpatients Treated with Cisplatin-Based Chemotherapy Using a Short Hydration Method
songül tezcan
Pharmacology & Pharmacy, 2013
View PDFchevron_right
Determining factors of renal dysfunction during cisplatin chemotherapy
Alina Negru
Experimental and Therapeutic Medicine, 2020
View PDFchevron_right